Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension

PHASE2RecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Orthostatic HypotensionAlzheimer Disease
Interventions
BEHAVIORAL

Routine treatment

Participants will be educated on ways to avoid induced hypotensive states, such as avoiding prolonged standing, standing after exercise, being nervous, eating several carbohydrate-rich foods, drinking alcohol, and being in a warm environment (such as a sauna). Participants will be encouraged in a comfortable home environment, such as a sit-down bath. If there are no contraindications, they are advised to increase their salt intake to approximately 10 grams per day and adjust their fluid intake to 2-3 liters per day. They will also be encouraged to perform lower-body strength training and moderate, non-strenuous activities. Seriously ill patients will be proposed to raise the head of their bed during sleep, wear tight clothing, eat small meals, and reduce alcohol intake.Concomitant treatment with cholinesterase inhibitors, memantine, or both was allowed.

DRUG

add-on low dose Astragalus

Participants received an additional 10g of astragalus per day.

DRUG

add-on high dose Astragalus

Participants received an additional 20g of astragalus per day.

Trial Locations (1)

350000

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER